Key BIOS facts and Figures – 2022

7 May 2022

Infographic

Medicines for Europe letter to EC on Divisionals & Patent Linkage re Fingolimod – 13.04.2022

3 May 2022

Policy

Removing access barriers in Central and Eastern Europe – April 2022

25 April 2022

Report

Factsheet: The EU Bolar Exemption

22 April 2022

Factsheet

Note on Transferable Vouchers – April 2022

22 April 2022

Policy

Biosimilar Medicines Reading List

18 April 2022

Factsheet

Podcast – Conversations on EU Pharma

10 April 2022

PODCAST

Medicines for Europe’s podcast exploring the off-patent medicines world Episode […]

Policy recommendations on uptake of biosimilar medicines in the retail market

5 November 2021

Policy

Policy recommendations on uptake of biosimilar medicines in the retail […]

Positioning Statements on Physician-led Switching for Biosimilar Medicines

1 October 2021

Policy

Positioning statements on physician-led switching for biosimilar medicines (October 2021) […]

Eco-Pharmaco-Stewardship (EPS) initiative – Care for People and Our Environment

30 September 2021

Report